| AE | Adverse event |
| AESI | Adverse event of special interest |
| FDA | Food and Drug Administration |
| GMFR | Geometric mean fold rise |
| GMT | Geometric mean titer |
| LLOQ | Lower limit of quantitation |
| N-binding | SARS-CoV-2 nucleoprotein-binding |
| NAAT | Nucleic acid amplification test |
| SAE | Serious adverse event |
| VE | Vaccine effectiveness |